𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized Trial of Alendronate Plus Vitamin D3Versus Standard Care in Osteoporotic Postmenopausal Women with Vitamin D Insufficiency

✍ Scribed by Stuart H. Ralston; Neil Binkley; Steven Boonen; Douglas P. Kiel; Jean-Yves Reginster; Christian Roux; Liang Chen; Elizabeth Rosenberg; Arthur Santora; Investigators of FOCUS-D (FOSAVANCE vs. Standard Care—Use and Study of Vitamin D) Trial


Publisher
Springer
Year
2011
Tongue
English
Weight
465 KB
Volume
88
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Effect of alendronate and vitamin D3 on
✍ Sue A Shapses; David L Kendler; Richard Robson; Karen E Hansen; Robert M Sherrel 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Menopause and increasing age are associated with a decrease in calcium absorption that can contribute to the pathogenesis of osteoporosis. We hypothesized that alendronate plus vitamin D~3~ (ALN + D) would increase fractional calcium absorption (FCA). In this randomized, double‐blind, p

The vitamin D analogue 2MD increases bon
✍ Hector F DeLuca; Wendy Bedale; Neil Binkley; J Chris Gallagher; Michael Bolognes 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 215 KB 👁 1 views

## Abstract Most osteoporosis drugs act by inhibiting bone resorption. A need exists for osteoporosis therapies that stimulate new bone formation. 2‐Methylene‐19‐nor‐(20__S__)‐1α,25‐dihydroxyvitamin D~3~ (2MD) is a vitamin D analogue that potently stimulates bone formation activity in vitro and in